Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 4/20 | 0.56 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.56 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.56 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.56 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.56 |
| ▸ | HRH1 | P35367 | 2/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.56 |
| ▸ | ESR1 | P03372 | 1/20 | 0.56 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.56 |
| ▸ | KCNE1 | P15382 | 1/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.56 |
| ▸ | HRH2 | P25021 | 1/20 | 0.56 |
| ▸ | HTR2A | P28223 | 1/20 | 0.56 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.56 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.56 |
| ▸ | KCNQ1 | P51787 | 1/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.56 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.56 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL5670305 | 0.99 | MAPT (0.55) | MAPTLMNACHRM1CHRM2CHRM5 | |
| Cadaverine Tartrate SCHEMBL5269127 | 0.92 | CHRM2 (0.62) | MAPTLMNACHRM1CHRM2CHRM5 | |
| Bromide SCHEMBL4662476 | 0.85 | MAPT (0.60) | MAPTLMNACHRM1CHRM2CHRM5 | |
| SCHEMBL1354181 | 0.84 | LMNA (0.40) | MAPTLMNACHRM1CHRM2CHRM5 | |
| SCHEMBL5683062 | 0.83 | IDO1 (0.40) | MAPTLMNACHRM1CHRM2CHRM5 | |
| SCHEMBL10514001 | 0.82 | TSHR (0.43) | MAPTLMNACHRM1CHRM2CHRM5 | |
| SCHEMBL2781332 | 0.81 | KMT2A (0.39) | MAPTLMNACHRM1CHRM2CHRM5 | |
| SCHEMBL8109866 | 0.79 | ERCC1 (0.39) | MAPTLMNACHRM1CHRM2CHRM5 | |
| Hydrochloric Acid SCHEMBL8096376 | 0.79 | IGF1R (0.37) | MAPTLMNACHRM1CHRM2CHRM5 | |
| SCHEMBL8106269 | 0.79 | CA12 (0.43) | MAPTLMNACHRM1CHRM2CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3104848-B1 | INHALABLE PARTICLE FORMULATIONS COMPRISING AN ANTIMUSCARINIC AGENT | CRYSTEC LTD (GB) | 2020-05-06 | — | — | EP | claimed |
| WO-2018035157-A1 | COMPOSITIONS AND METHODS OF TREATING A NEURODEGENERATIVE DISEASE | AXOVANT SCIENCES GMBH (CH) | 2018-02-22 | — | — | WO | claimed |
| EP-2323967-A2 | FESOTERODINE COMPRISING A REDUCED AMOUNT OF DEHYDROXYFESOTERODINE | Actavis Group PTC EHF (IS) | 2011-05-25 | — | — | EP | claimed |
| WO-2010010464-A2 | FESOTERODINE SUBSTANTIALLY FREE OF DEHYDROXY IMPURITY | ACTAVIS GROUP PTC EHF (IS) | 2010-01-28 | — | — | WO | claimed |
| EP-1434574-A2 | TOLTERODINE METABOLITES | Bridge Pharma, Inc. (US) | 2004-07-07 | — | — | EP | claimed |
| WO-2003002059-A2 | TOLTERODINE METABOLITES | BRIDGE PHARMA, INC. (US) | 2003-01-09 | — | — | WO | claimed |
| US-11759420-B2 | Inhalable particles | CRYSTEC LTD (GB) | 2023-09-19 | — | — | US | disclosed |
| CN-115406975-A | Tolterodine tartrate raw material and method for detecting ethanol in preparation of tolterodine tartrate raw material | 山东新时代药业有限公司 | 2022-11-29 | — | — | CN | disclosed |
| US-20220331243-A1 | INHALABLE PARTICLES | CRYSTEC LTD (GB) | 2022-10-20 | — | — | US | disclosed |
| CN-115112784-A | Method for detecting enantiomer in tolterodine tartrate | 山东新时代药业有限公司 | 2022-09-27 | — | — | CN | disclosed |
| US-11351115-B2 | Inhalable particles | CRYSTEC LTD (GB) | 2022-06-07 | — | — | US | disclosed |
| US-20200230053-A1 | Inhalable Particles | CRYSTEC LTD (GB) | 2020-07-23 | — | — | US | disclosed |
| EP-3104848-B1 | INHALABLE PARTICLE FORMULATIONS COMPRISING AN ANTIMUSCARINIC AGENT | CRYSTEC LTD (GB) | 2020-05-06 | — | — | EP | disclosed |
| EP-1496882-A1 | TOLTERODINE SALTS | Pharmacia & Upjohn Company LLC (US) | 2005-01-19 | — | — | EP | disclosed |
| WO-2004105735-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF TOLTERODINE AND PROCESSES FOR THEIR PREPARATION | RANBAXY LABORATORIES LIMITED (IN) | 2004-12-09 | — | — | WO | disclosed |
| EP-1461306-A1 | QUATERNARY AMMONIUM COMPOUNDS AND THEIR USE AS ANTIMUSCARINIC AGENTS | PHARMACIA & UPJOHN COMPANY (US) | 2004-09-29 | — | — | EP | disclosed |
| WO-2003090734-A1 | TOLTERODINE SALTS | PHARMACIA & UPJOHN COMPANY LLC. (US) | 2003-11-06 | — | — | WO | disclosed |
| WO-2003035599-A1 | QUARTERNARY AMMONIUM COMPOUNDS AND THEIR USE AS ANTIMUSCARINIC AGENTS | PHARMACIA & UPJOHN COMPANY (US) | 2003-05-01 | — | — | WO | disclosed |
| EP-1039882-A1 | THERAPEUTIC FORMULATION FOR ADMINISTERING TOLTERODINE WITH CONTROLLED RELEASE | Pharmacia & Upjohn Aktiebolag (SE) | 2000-10-04 | — | — | EP | disclosed |
| WO-2000012069-A1 | THERAPEUTIC FORMULATION FOR ADMINISTERING TOLTERODINE WITH CONTROLLED RELEASE | PHARMACIA & UPJOHN AB (SE) | 2000-03-09 | — | — | WO | disclosed |